000 01329 a2200397 4500
005 20250514053410.0
264 0 _c20030102
008 200301s 0 0 fre d
022 _a0248-8663
024 7 _a10.1016/s0248-8663(02)00707-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCeccaldi, B
245 0 0 _a[Dysarthria during irinotecan administration].
_h[electronic resource]
260 _bLa Revue de medecine interne
_cNov 2002
300 _a950-1 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents, Phytogenic
_xadministration & dosage
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aDiagnosis, Differential
650 0 4 _aDysarthria
_xchemically induced
650 0 4 _aEndometrial Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIrinotecan
650 0 4 _aMagnetic Resonance Imaging
700 1 _aKara, F
700 1 _aMommeja-Marin, H
700 1 _aBègue, M
700 1 _aSaint Blancard, P
700 1 _aLe Marec, E
700 1 _aHauteville, D
773 0 _tLa Revue de medecine interne
_gvol. 23
_gno. 11
_gp. 950-1
856 4 0 _uhttps://doi.org/10.1016/s0248-8663(02)00707-5
_zAvailable from publisher's website
999 _c12285917
_d12285917